Oman vs Zambia: The number of people with susceptibility test result for rifampicin
Oman
84.21
in 2021
Zambia
85.35
in 2021
Oman rank
87th
Zambia rank
84th
The number of people with susceptibility test result for rifampicin over time
- Oman
- Zambia
How they compare
Zambia currently reports 85.35 against 84.21 in Oman, a difference of 1.14.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Oman ahead.
Oman ranks 87th and Zambia ranks 84th of 146 countries.
Across the 2 decades both report, Oman averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | Oman | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 65.88 | 34.12 | Oman |
| 2020s | 87.9 | 88.01 | 0.1041 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Oman or Zambia?
- Zambia, at 85.35 against 84.21 in Oman as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Oman and Zambia?
- 1.14, with Zambia ahead.
- How many years of comparable data are there for Oman and Zambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Oman and Zambia rank globally for the number of people with susceptibility test result for rifampicin?
- Oman ranks 87th and Zambia ranks 84th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.